Default: Bone

ISSN: 8756-3282

Journal Home

Journal Guideline

Bone Q1 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bone is a journal indexed in SJR in Physiology and Endocrinology, Diabetes and Metabolism with an H index of 200. It has a price of 2385 €. It has an SJR impact factor of 1,346 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,346.

Bone focuses its scope in these topics and keywords: bone, mass, fractures, gene, mineral, alterations, osteomalacia, therapy, model, osteoporosis, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2385 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Bone

1,346

SJR Impact factor

200

H Index

420

Total Docs (Last Year)

942

Total Docs (3 years)

24005

Total Refs

4238

Total Cites (3 years)

910

Citable Docs (3 years)

4,05

Cites/Doc (2 years)

57,15

Ref/Doc

Other journals with similar parameters


Circulation Q1
Circulation Research Q1
Nature Metabolism Q1
Sleep Medicine Reviews Q1
BMC Biology Q1

Compare this journals

Aims and Scope


bone, mass, fractures, gene, mineral, alterations, osteomalacia, therapy, model, osteoporosis, factor, density, strength, formation, caused, macrophagecolony, loss, femoral, fracture, genes, growth, homozygous, hormone, human, induced,



Best articles by citations

Parathyroid hormone-stimulated resorption in calvaria cultured in serum-free medium is enhanced by the calcium-mobilizing activity of 1,25-Dihydroxyvitamin D3

View more

Histomorphometric and biochemical characterization of bone following acute severe burns in children

View more

Efficacy of intravenous pamidronate in the treatment of patients with osteoporosis

View more

Effects of Bisphosphonates APD and HEBP on Bone Metabolism In Vitro

View more

Epidemiology of fractures in Chile

View more

Prevention of steroid-induced osteoporosis with intermittent intravenous pamidronate : A randomized trial

View more

Cyclical intravenous clodronate in postmenopausal osteoporosis: A 6-year clinical trial

View more

Expression of metalloproteinase-13 (collagenase-3) is induced during fracture healing in mice

View more

Biochemical markers of bone metabolism after short and long time ethanol withdrawal in alcoholics

View more

The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in central Finland

View more

Transcriptional regulation of cytochrome P-450 aromatase gene (CYP19) in human osteoblasts in primary cultures

View more

Stochastically simulated assessment of anabolic treatment following varying degrees of cancellous bone resorption

View more
SHOW MORE ARTICLES

Medical management of primary hyperparathyroidism

View more

Could some biomechanical effects of growth hormone help to explain its effects on bone formation and resorption?

View more

Efficiency of strategies to identify postmenopausal women with osteoporosis in Mexico

View more

Muscle-bone interactions, revisited

View more

Changes in parathyroid hormone-related protein and vascular endothelium growth factor in human osteoblasts: relationship with donor age and skeletal site

View more

Aging and accumulation of microdamage in canine bone

View more

A low calcium diet during pregnancy and lactation of rats decreases their bone mineral density, milk production, litter weight, and body calcium

View more

Letters to the editor

View more

New treatments in osteoporosis

View more

Intravenous pamidronate increases bone mineral density and reduces bone remodeling markers in fibrous dysplasia

View more

A new SNP region in the regulatory region of COLIA1 is associated with bone mineral density in perimenopausal Spanish women

View more

Letters to the editor

View more

Comments

No comments ... Be the first to comment!

FAQS